Share on LinkedInShare on LinkedIn

ARTICLE · 04 JULY 2025

U.S. Merger Remedies See Revival As Antitrust Agencies Conditionally Clear Five Cases

A&O Shearman
A&O Shearman
Contributor

A&O Shearman

Introducing A&O Shearman Unparalleled global depth for a changing world. Today more than ever,...

View firm profile
Explore more from A&O Shearman

Under the Biden administration, the U.S. antitrust agencies, particularly the U.S. Department of Justice Antitrust Division (DOJ or Antitrust Division), were unusually resistant to negotiated merger remedies.

United StatesAntitrust/Competition Law

Under the Biden administration, the U.S. antitrust agencies, particularly the U.S. Department of Justice Antitrust Division (DOJ or Antitrust Division), were unusually resistant to negotiated merger remedies. Instead, they preferred to challenge deals or see transactions restructured outside the normal consent decree process, expressing skepticism as to whether remedies—even structural divestments—could effectively address antitrust concerns.

In fact, only six U.S. consent decrees were entered into during 2023 and 2024. Our global trends in merger control enforcement report gives more data and commentary. In the report, we predict a return to pre-Biden levels of merger control enforcement under the Trump administration's pro-business agenda, translating to a greater willingness to accept merger remedies.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from